Immunotherapy Advances Lung Cancer Treatment Landscape
Benjamin Levy, MD, discusses how the role of immunotherapy has evolved in the treatment landscape of lung cancer and where he sees this research headed in the future.
Multiple Therapies Show Responses in Lung Cancer With ROS1 Fusions
Ben Levy, MD, discusses the mechanism of resistance such as the G2032R solvent front mutation in patients who received crizotinib for lung cancer with ROS1 fusions and how to treat them.